Eligible Countries
Eligible Countries
54 countries will be eligible to apply for Gavi support in 2022 based on a Gross National Income (GNI) per capita below or equal to US$ 1,630 on average over the past three years. Gavi sets conditions for each type of support.
Gavi currently has 73 implementing countries while IFFIm has 71. Countries that are not members of the IMF will not benefit from IFFIm funds; this restriction currently applies to Cuba and the Democratic People’s Republic of Korea.
Investing in Gavi’s 2021-2025 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness.
US$ 80-100 billion
Countries eligible to apply for Gavi support in 2022
- Afghanistan
- Bangladesh
- Benin
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Central African Republic
- Chad
- Comoros
- Côte d'Ivoire
- Democratic Republic of Korea**
- Democratic Republic of the Congo
- Djibouti
- Eritrea
- Ethiopia
- Gambia
- Ghana
- Guinea
- Guinea Bissau
- Haiti
- Kenya
- Kyrgyzstan
- Lao People's Democratic Republic
- Lesotho
- Liberia
- Madagascar
- Malawi
- Mali
- Mauritania
- Mozambique
- Myanmar
- Nepal
- Niger
- Nigeria
- Pakistan
- Papua New Guinea
- Republic of Congo
- Republic of Sudan
- Rwanda
- Sâo Tomé
- Senegal
- Sierra Leone
- Solomon Islands
- Somalia
- South Sudan
- Syria
- Tajikistan
- Tanzania
- Togo
- Uganda
- Yemen
- Zambia
- Zimbabwe
Gavi aims to focus its support on the world’s poorest countries with national incomes determining eligibility.
Countries are eligible to apply for Gavi support when their Gross National Income (GNI) per capita is below or equal to US$ 1,630 on average over the past three years (according to World Bank data published every year on 1 July).
Each type of Gavi support has certain conditions countries have to fulfil in order to be eligible to apply. Country applications are reviewed by an independent group of experts in routine immunisation, health system strengthening, epidemiology and disease control, cold chain and logistics, financial and budget analysis, and gender and equity.
Countries whose average GNI per capita over the previous three years crosses the Gavi eligibility threshold enter the accelerated transition phase and start phasing out of Gavi support. Based on the Gavi Board decision in November 2013, Gavi’s policy for countries in transition have been adjusted to allow the following:
Countries entering the accelerated transition phase will have one additional year (“grace year”) to apply for new vaccine support.
Countries in the accelerated transition phase with DTP3 (three doses of diphtheriatetanus-pertussis vaccine) coverage below 90% (WHO/UNICEF estimates for the previous year) are entitled to apply for health system strengthening support for the duration of the accelerated transition phase.
*In the event that a Gavi-eligible country is in protracted arrears with the International Monetary Fund (IMF), Gavi will not use funds generated by IFFIm to support this country’s immunisation programmes. More information on IMF protracted arrears can be found on the IMF website.
** Gavi does not use funds generated by IFFIm to support this country’s immunisation programmes.
IFFIm's contributions have made it possible for Gavi to immunise more children, faster. Since 2006, IFFIm has transferred more than US$ 5.4 billion to support Gavi’s vaccination programmes. This represents about one-sixth of Gavi's overall funding.
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.